Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
November 2025
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
Specific Salmonella detection agar
, /in Product News /by 3wmediaIt is often a challenge to identify Salmonella species in samples heavily contaminated with competing microbiological flora, so Lab M has added new Xylose Lysine Tergitol-4 (XLT4) agar to its extensive range of products for Salmonella isolation and identification. XLT4 is a highly selective and very cost-effective medium for the specific detection and enhanced recovery of non-typhi Salmonella species from clinical (and other) samples. It enables labs to rapidly determine whether or not these pathogenic organisms are present, for effective monitoring even when faced with difficult materials.
Read more
Rapid H. pylori detection test
, /in Product News /by 3wmediaInfection with Helicobacter pylori is estimated to affect 40 – 50 % of the population, and can have a significant impact on the treatment of patients with gastroduodenal diseases, gastric cancers and unexplained iron deficiency anaemia. The PYLORITOP Ag+ rapid visual assay for the detection of H. pylori in faecal samples is an immunochromatogenic test designed to provide clinical laboratories with a cost-effective assay to help meet current guidelines for the detection and treatment of H. pylori. The assay provides a quick noninvasive test for H. pylori infection, offering rapid qualitative results in just five minutes to help guide clinical pathways and avoid unnecessary treatments. Based on robust lateral flow technology, individually wrapped test cassettes are supplied with a sample collection tube for maximum convenience, and can be safely stored at room temperature for up to 12 months, providing a practical solution for H. pylori testing.
Read more
Vitamin D LC-MS/MS analysis kit
, /in Product News /by 3wmediaThis unique kit enables the exact analysis of 1,25(OH)2 Vitamin D3/D2 with high specificity and sensitivity and without ion suppression by interfering matrix components. This is due to a superior sample preparation step: Vitamin D is extracted from clinical specimens in a specific single-step affinity purification with the ID Immunotube, thereby separating it from disturbing matrix components and isobaric interferences. The published and market proven product is suitable for flexible use on high-end LC-MS/MS instruments.
Read more
Rapid urine test for kidney injury
, /in Product News /by 3wmediaKidney injury molecule-1 (Kim-1) has been qualified by the Food and Drug Administration and European Medicines Agency as a highly sensitive and specific urinary biomarker to monitor drug-induced kidney injury in preclinical studies and on a case-by-case basis in clinical trials. The urinary Kim-1 band intensity using the Kim-1 dipstick significantly correlated with levels of Kim-1 as measured by a microbead-based assay, histopathological damage, and immunohistochemical assessment of renal Kim-1 in a dose- and time-dependent manner. Kim-1 was detected following kidney injury induced in rats by cadmium, gentamicin, or bilateral renal ischaemia/reperfusion. In humans, the urinary KIM-1 band intensity was significantly greater in urine from patients with acute kidney injury than in urine from healthy volunteers. The KIM-1 dipstick also enabled temporal evaluation of kidney injury and recovery in two patients who developed postoperative acute kidney injury following cytoreductive surgery for malignant mesothelioma with intraoperative local cisplatin administration.
Read more
Energy efficient sample storage
, /in Product News /by 3wmediaThese innovative new ultra-low temperature (ULT) freezers have been designed to provide laboratories with an energy efficient approach to cold storage. The Thermo Scientific Revco UxF Series incorporates users’ choice of high-performance or energy saving modes, which are easily selected via the intuitive touch-screen interface. This new range of freezers provides outstanding sample protection while using significantly less energy than previous generation models. The series helps laboratories to obtain an energy-efficient approach to maintaining sample viability during long- and short-term cold storage. In addition to providing efficient operation, the series offers temperature uniformity throughout the internal chamber. As a result, users can maximise the use of all available space with the knowledge that all samples will be held at the pre-set optimal temperature.
Read more
Listeria monoclonal antibodies
, /in Product News /by 3wmediaListeriosis is a serious infection caused by the bacterium Listeria monocytogenes. This infection is contracted by eating contaminated food. The infection can lead to miscarriage, stillbirth and meningitis. An outbreak in 2011 involving contaminated cantaloupes lead to 30 deaths. A new set of recently released monoclonal antibodies to Listeria also contains several that are specific to the p60 protein that is secreted by the organism during growth in culture or in contaminated food. Thus these antibodies offer potential tools for the rapid detection of this food pathogen.
Read more
Bordetella pertussis test kit
, /in Product News /by 3wmediaPertussis toxin is a protein exclusively produced by the bacterium Bordetella pertussis, which causes the respiratory infectious disease pertussis (whooping cough) in humans. The typical symptoms are frequent and severe cough attacks with a whooping sound and vomiting. The infection can be fatal for infants that have not yet been vaccinated against pertussis. Vaccination does not provide lifelong protection. Adult pertussis can be difficult to diagnose due to milder symptoms and often due to the lack of the characteristic whooping sound and vomiting. Adults with pertussis are therefore the main source of infection for unvaccinated infants. Diagnosis and treatment of adult pertussis can eventually reduce infant pertussis cases. Bordetella pertussis is only present in the airways for the first few weeks after the infection but the symptoms last for a longer period due to presence of the toxin and several other virulence factors. Diagnostic methods detecting the bacterium itself (culture and PCR) are therefore only useful early in the infection. Serology is, however, very efficient for diagnosis of patients with prolonged cough. Pertussis toxin is the recommended antigen for pertussis ELISA as there is no risk of cross-reactions with other bacterial antigens. The Bordetella pertussis IgG-PT ELISA kit is a traditional ELISA setup, which has been developed using purified pertussis toxin. Four standard samples are provided to establish the standard curve. The dilution method is the same for the standards and samples. Heat-treated sera can be analysed with this method without the risk of false-positive results. The sensitivity and specificity value is 81 % and 96 % respectively based on data from Denmark using a cut-off at 75 IU/mL. The test can be carried out either in one day or with overnight incubation for the first step. The plate can be split to facilitate more than one run of the kit. The kit contains enough reagents including controls to perform 24 – 44 test. Shelf life is minimum one year from date of shipment.
Read more
Aspergillus detection test
, /in Product News /by 3wmediaAn evaluation to detect invasive Aspergillosis (IA) in a mixed population of 158 patients with underlying haematological or critical illness using the new commercial PCR test, the MycAssay, has been completed. The single-centre prospective evaluation tested the reliability and performance of the assay compared with clinical diagnosis and conventional diagnostic tests, such as culture and one of the current commercial gold-standards which is based around the detection of galactomannan (GM) in serum. The data generated from bronchoalveolar lavage [BAL] samples showed that the assay is a sensitive and specific molecular test for the diagnosis of IA which, in these early studies, appears to perform better than other assays in the study and is far superior to culture. Invasive aspergillosis is usually a hidden, clinical silent disease. Early detection of IA is critical for improved patient outcomes. Current tests are insensitive or suffer from false-positive and false-negative results. These new data are very promising in the context of haematological or critical illness and hopefully can be introduced into routine fungal disease guidelines at the earliest opportunity.
Read more
Semi-auto chemistry analyser
, /in Product News /by 3wmediaThe KL-800 Semi-Auto Chemistry Analyser offers four channels designed to carry out four simultaneous tests, eight filters (340nm~700nm) and allows up to 200 tests to be programmed. It is energy efficient with a sleep mode to prolong the lifespan of the light source and equipped with power failure protection. The analyser is available with a standard RS232 interface and optional touch-screen, keyboard and mouse. It offers real time monitoring of reaction curve and process, an auto wash feature and an accurate temperature control system.
Read more
Diagnostic test for chronic wounds
, /in Product News /by 3wmediaAlthough widely understood and recognised as a key marker in wound healing, currently elevated protease activity (EPA) in chronic wounds goes undetected as there are no visual cues for it. A recently published study showed that chronic wounds with EPA have a 90% probability that they will not heal without appropriate intervention. The estimated 30 million chronic wounds treated each year account for approximately 3% of total health expenditure. Until now, with almost 30% of non-healing wounds having EPA, the absence of a test could result in ineffective treatment choices, leading to significant cost to healthcare providers. Wound care clinicians’ calls for better diagnostic tools to aid wound assessment have now been answered with the CE marking of WOUNDCHECK Protease Status, the world’s first rapid, point-of-care diagnostic test developed specifically for chronic wounds. It has the potential to revolutionise wound care by enabling early, targeted intervention and cost-effective use of advanced therapies to modulate protease activity. Designed to form part of routine wound assessment, the test is easy-to-use and provides results in just 15 minutes at the point of care. This enables the test to immediately influence treatment decisions and help clinicians target advanced wound care therapies more effectively by identifying when EPA exists in chronic wounds. As the implementation of point-of-care testing is new to many wound care clinicians, there is a new online training tool for the training of prospective users.
Read more